Clinical outcomes of temocillin use for invasive Enterobacterales infections: a single-centre retrospective analysis

BACKGROUND: With increasing frequency of resistant Gram-negative bacteria, temocillin has potential utility in reducing carbapenem use. The 2020 EUCAST guideline changes temocillin breakpoints and reclassifies isolates with an MIC of 0.001–16 mg/L as ‘susceptible, increased exposure’ necessitating 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Heard, Katie L, Killington, Kieran, Mughal, Nabeela, Moore, Luke S P, Hughes, Stephen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210019/
https://www.ncbi.nlm.nih.gov/pubmed/34223083
http://dx.doi.org/10.1093/jacamr/dlab005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8210019/
https://www.ncbi.nlm.nih.gov/pubmed/34223083
http://dx.doi.org/10.1093/jacamr/dlab005

Ejemplares similares